These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 28677801

  • 1. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.
    Xu Y, Zheng Y, Liu H, Li T.
    Int J Oncol; 2017 Sep; 51(3):791-800. PubMed ID: 28677801
    [Abstract] [Full Text] [Related]

  • 2. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
    Li ML, Zhang Y, Ma LT.
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1.
    Jiang T, Li M, Li Q, Guo Z, Sun X, Zhang X, Liu Y, Yao W, Xiao P.
    Oncol Res; 2017 Aug 07; 25(7):1117-1127. PubMed ID: 28244848
    [Abstract] [Full Text] [Related]

  • 4. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
    Zhang Q, Cheng S, Cao L, Yang J, Wang Y, Chen Y.
    Biosci Rep; 2020 Mar 27; 40(3):. PubMed ID: 32077915
    [Abstract] [Full Text] [Related]

  • 5. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
    Wang J, Luo Z, Yao T, Li W, Pu J.
    J Cell Physiol; 2019 May 27; 234(5):6908-6916. PubMed ID: 30317590
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro.
    Luo M, Xiong Y, Lin Y, Liang R, Li Y, Ge L.
    Med Sci Monit; 2021 May 15; 27():e930215. PubMed ID: 33990536
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J, Chen X, Hou Y, Kang G, Li Q, Xu Y.
    Biomed Pharmacother; 2018 Nov 15; 107():824-833. PubMed ID: 30142544
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LINC00467 promotes cell proliferation and metastasis by binding with IGF2BP3 to enhance the mRNA stability of TRAF5 in hepatocellular carcinoma.
    Jiang W, Cheng X, Wang T, Song X, Zheng Y, Wang L.
    J Gene Med; 2020 Mar 15; 22(3):e3134. PubMed ID: 31656043
    [Abstract] [Full Text] [Related]

  • 12. SOX12 upregulation is associated with metastasis of hepatocellular carcinoma and increases CDK4 and IGF2BP1 expression.
    Yuan P, Meng L, Wang N.
    Eur Rev Med Pharmacol Sci; 2017 Oct 15; 21(17):3821-3826. PubMed ID: 28975985
    [Abstract] [Full Text] [Related]

  • 13. Long non‑coding RNA AB019562 promotes cell proliferation and metastasis in human hepatocellular carcinoma.
    Wu F, Li J, Du X, Zhang W, Lei P, Zhang Q.
    Mol Med Rep; 2017 Jul 15; 16(1):69-74. PubMed ID: 28534955
    [Abstract] [Full Text] [Related]

  • 14. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
    Wei C, Wang H, Xu F, Liu Z, Jiang R.
    Biomed Pharmacother; 2018 Aug 15; 104():137-144. PubMed ID: 29772433
    [Abstract] [Full Text] [Related]

  • 15. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X, Sun L, Wang L, Yao B, Mo H, Yang W.
    Biomed Pharmacother; 2019 Oct 15; 118():109386. PubMed ID: 31545291
    [Abstract] [Full Text] [Related]

  • 16. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 17. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA.
    He J, Zuo Q, Hu B, Jin H, Wang C, Cheng Z, Deng X, Yang C, Ruan H, Yu C, Zhao F, Yao M, Fang J, Gu J, Zhou J, Fan J, Qin W, Yang XR, Wang H.
    Cancer Lett; 2019 May 28; 450():98-109. PubMed ID: 30790682
    [Abstract] [Full Text] [Related]

  • 18. LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression.
    Zhang J, Hu K, Yang YQ, Wang Y, Zheng YF, Jin Y, Li P, Cheng L.
    Cell Death Dis; 2020 Sep 11; 11(9):741. PubMed ID: 32917856
    [Abstract] [Full Text] [Related]

  • 19. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
    Peng W, Fan H.
    Biomed Pharmacother; 2016 Oct 11; 83():450-455. PubMed ID: 27427851
    [Abstract] [Full Text] [Related]

  • 20. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L, Han T, Liu K, Lei CG, Wang ZC, Shi GJ.
    Eur Rev Med Pharmacol Sci; 2019 Jun 11; 23(12):5392-5401. PubMed ID: 31298392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.